Dosages for treatment with anti-ERBB2 antibodies

Details for Australian Patent Application No. 2009201871 (hide)

Owner Genentech, Inc.

Inventors Baughman, Sharon Ann; Shak, Steven

Agent Griffith Hack

Pub. Number AU-A-2009201871

Parent 2006200146

Filing date 12 May 2009

Wipo publication date 4 June 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

28 May 2009 Complete Application Filed

4 June 2009 Application Open to Public Inspection

  Published as AU-A-2009201871

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201872-Furcation bodies and fiber optic assemblies using the same

2009201870-Vehicle coupling device